Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.50 |
| ▸ | MAPT | P10636 | 4/20 | 0.50 |
| ▸ | MEN1 | O00255 | 2/20 | 0.48 |
| ▸ | HPGD | P15428 | 2/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.48 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.48 |
| ▸ | GAA | P10253 | 1/20 | 0.48 |
| ▸ | CES1 | P23141 | 3/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | CES2 | O00748 | 2/20 | 0.47 |
| ▸ | TSHR | P16473 | 2/20 | 0.47 |
| ▸ | DAO | P14920 | 1/20 | 0.47 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28574890 | 0.97 | MAPT (0.48) | ALDH1A1MAPTMEN1HPGDKMT2A | |
| SCHEMBL27875154 | 0.97 | MAPT (0.48) | ALDH1A1MAPTMEN1HPGDKMT2A | |
| Dimethylamine SCHEMBL27592657 | 0.88 | MAPT (0.48) | ALDH1A1MAPTMEN1HPGDKMT2A | |
| SCHEMBL4253421 | 0.86 | RAB9A (0.52) | ALDH1A1MAPTMEN1KMT2AL3MBTL1 | |
| SCHEMBL9148333 | 0.84 | ALDH1A1 (0.44) | ALDH1A1MAPTMEN1HPGDKMT2A | |
| SCHEMBL17115264 | 0.84 | KMT2A (0.60) | ALDH1A1MEN1HPGDKMT2AL3MBTL1 | |
| SCHEMBL6338854 | 0.84 | CES2 (0.60) | ALDH1A1MAPTMEN1HPGDKMT2A | |
| Pyridine SCHEMBL29039599 | 0.84 | ALDH1A1 (0.48) | ALDH1A1MAPTMEN1HPGDKMT2A | |
| SCHEMBL10454001 | 0.84 | CES2 (0.60) | ALDH1A1MAPTMEN1KMT2AL3MBTL1 | |
| SCHEMBL28052776 | 0.84 | MAPT (0.48) | ALDH1A1MAPTMEN1KMT2AL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 603 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119662109-A | Ultraviolet-resistant polyurethane coating and preparation method thereof | 清远市美佳乐环保新材股份有限公司 | 2025-03-21 | — | — | CN | claimed |
| CN-118994727-A | Ultraviolet-resistant artificial leather surface treating agent and preparation method thereof | 清远市美佳乐环保新材股份有限公司 | 2024-11-22 | — | — | CN | claimed |
| EP-4165020-A1 | CONTINUOUS PHOTOCHEMICAL PRODUCTION OF HIGH PURITY LINEAR MERCAPTAN AND SULFIDE COMPOSITIONS | Arkema, Inc. (US) | 2023-04-19 | — | — | EP | claimed |
| CN-115093557-A | Modified dendritic self-initiated UV resin and preparation method thereof | 韶关市合众化工有限公司 | 2022-09-23 | — | — | CN | claimed |
| CN-111909379-B | Preparation method of thioether polymer | 江汉大学 | 2022-09-20 | — | — | CN | claimed |
| CN-112645862-B | Pirfenidone photodegradation impurities and preparation method thereof | 南京华威医药科技集团有限公司 | 2022-04-01 | — | — | CN | claimed |
| WO-2021252273-A1 | CONTINUOUS PHOTOCHEMICAL PRODUCTION OF HIGH PURITY LINEAR MERCAPTAN AND SULFIDE COMPOSITIONS | ARKEMA INC. (US) | 2021-12-16 | — | — | WO | claimed |
| US-11161810-B1 | Continuous photochemical production of high purity linear mercaptan and sulfide compositions | ARKEMA INC. (US) | 2021-11-02 | — | — | US | claimed |
| CN-112645862-A | Pirfenidone photodegradation impurities and preparation method thereof | 南京华威医药科技集团有限公司 | 2021-04-13 | — | — | CN | claimed |
| CN-108755112-B | Antibacterial modification method of high polymer material | 济南鸿湾生物技术有限公司 | 2020-09-25 | — | — | CN | claimed |
| US-4555547-A | POLYBUTADIENE CONTAINING BENZOPHENONE OR THIOBENZOPHENONE UNITS INTHE CHAIN | NIPPON ZEON CO. LTD. (JP) | 1985-11-26 | — | — | US | claimed |
| US-4415650-A | VACUUM DEPOSITING AN ORGANIC AND AN INORGANIC COMPOUND ON A SUPPORT; THERMOSENSITIVITY; LASERS | FUJI PHOTO FILM CO., LTD. (JP) | 1983-11-15 | — | — | US | claimed |
| US-4286045-A | A SUPPORT HAVING A LAYER OF A CHALCOGENIDE OF GERMANIUM DOPED WITH SILVER OR COPPER; STABILITY; LITHOGRAPHIC PRINTING PLATES | FUJI PHOTO FILM CO., LTD. (JP) | 1981-08-25 | — | — | US | claimed |
| US-4271256-A | PHOTOENGRAVING | FUJI PHOTO FILM CO., LTD. (JP) | 1981-06-02 | — | — | US | claimed |
| EP-0005400-B1 | PROCESS FOR THE SYNTHESIS OF MERCAPTANS | SOCIETE NATIONALE ELF AQUITAINE (FR) | 1981-04-15 | — | — | EP | claimed |
| US-4233128-A | PHOTOCHEMISTRY, UNSATURATED COMPOUND AND HYDROGEN SULFIDE, VA ELEMENT PROMOTER, (THIO)BENZOPHENONE | SOCIETE NATIONALE ELF-AQUITAINE (PRODUCTION) (FR) | 1980-11-11 | — | — | US | claimed |
| US-4198237-A | GERMANIUM SULFIDE | FUJI PHOTO FILM CO., LTD. (JP) | 1980-04-15 | — | — | US | claimed |
| US-4197124-A | SILVER OR COPPER AND SULFUR, SELENIUM OR TELLURIUM0 | FUJI PHOTO FILM CO., LTD. (JP) | 1980-04-08 | — | — | US | claimed |
| EP-0005400-A1 | Process for the synthesis of mercaptans | SOCIETE NATIONALE ELF AQUITAINE (FR) | 1979-11-14 | — | — | EP | claimed |
| US-4060562-A | SULFUR CONTAINING CATALYST | BAYER AKTIENGESELLSCHAFT (DT) | 1977-11-29 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11161810-B1 | Continuous photochemical production of high purity linear mercaptan and sulfide compositions | TST, MPST, MGMT | ALDH1A1 921/4885MAPT 1640/4885MEN1 2348/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.